The Mexico vaccine market was valued at USD 2.33 Billion in 2025, driven by the robust government immunization programs and innovations in vaccine technology in the region. The market is anticipated to grow at a CAGR of 5.30% during the forecast period of 2026-2035, with the values likely to reach USD 3.91 Billion by 2035.
Base Year
Historical Period
Forecast Period
The high burden of vaccine-preventable diseases, including influenza, hepatitis, human papillomavirus (HPV), and respiratory infections, is a primary driver of the market in Mexico.
The rise in large-scale vaccination campaigns aimed at expanding vaccine coverage is projected to boost the Mexico vaccine market demand in the forecast period.
The growing adoption of advanced vaccines, such as mRNA and vector-based vaccines, is a significant market trend in the country.
Compound Annual Growth Rate
5.3%
Value in USD Billion
2026-2035
*this image is indicative*
In Mexico, the vaccine market is witnessing significant growth, driven by the rising disease prevalence and increased government and private sector investment in immunization infrastructure. National programs, such as the National Vaccination Campaign against Influenza and COVID-19 (2024–2025), play a substantial role in boosting vaccine uptake, especially among vulnerable populations. Moreover, the increasing collaboration between government agencies and pharmaceutical companies is leading to improved vaccine delivery and storage, which is projected to positively impact the market dynamics.
Rising Vaccine-Preventable Disease Incidence to Boost Market Growth
The increasing prevalence of infectious diseases is a major driver for the vaccine market in Mexico. It is reported that the country faces a significant burden from vaccine-preventable diseases. According to the World Health Organization (WHO), Mexico recorded 333,980 deaths from communicable, maternal, perinatal, and nutritional conditions in 2021, with 19,469 deaths attributed to infectious and parasitic diseases. Respiratory infections accounted for 292,606 deaths, as per the WHO Mortality Database. This rising disease incidence, especially among vulnerable groups such as the elderly and individuals with chronic conditions, is expected to augment the market demand in the coming years.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
Market Breakup by Type
Market Breakup by Route of Administration
Market Breakup by Disease Indication
Market Breakup by Age
Market Breakup by End User
Segmentation by Product Type Set to Hold High Market Value
Based on the product type, the vaccine market in Mexico is segmented into multivalent and monovalent vaccines. The multivalent vaccine segment is likely to hold a dominant market share owing to its efficiency, cost-effectiveness, and ease of administration. These vaccines reduce the number of injections needed, improving compliance, especially in pediatric and elderly populations. Multivalent vaccines such as the DTP (diphtheria, tetanus, pertussis), MMR (measles, mumps, rubella), and pentavalent vaccines are widely administered as part of the National Immunization Program in the country.
In Mexico, the market dynamics vary significantly across different regions, influenced by factors such as healthcare infrastructure, population density, and public health initiatives. The central region, including Mexico City and Estado de México, is expected to lead the market share, owing to the high population density, advanced healthcare infrastructure, and the presence of key government health institutions. Additionally, high vaccination coverage in this region is driven by robust public health campaigns, including seasonal vaccinations like flu and COVID-19.
The key features of the market report comprise patent analysis, clinical trials analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
GSK is a key player in advancing immunization coverage across Mexico, particularly through its focus on public-private partnerships and community-level health initiatives. The company supports Mexico’s vaccination goals by introducing next-generation vaccines. GSK is also actively involved in educational outreach, working alongside healthcare providers to boost awareness around preventable diseases.
Merck has a strong presence in the Mexico vaccine market. It delivers high-quality vaccines and supports evidence-based health initiatives. Merck's HPV vaccine is widely used to reduce cervical cancer rates, particularly through school-based immunization programs. The company collaborates with Mexican researchers and institutions to strengthen local clinical trial networks.
Sanofi is known for playing a prominent role in making immunization more inclusive and accessible throughout Mexico. The company works closely with public health agencies to improve childhood vaccination rates in both urban and remote regions. Sanofi also actively contributes to pandemic preparedness by supporting influenza surveillance systems in Mexico.
Pfizer Inc., a global biopharmaceutical company, supports nationwide immunization strategies with its pneumococcal and meningococcal vaccines. The company collaborates with healthcare professionals to train staff in vaccine administration and improve cold chain logistics. To support equitable access, Pfizer partners with local and regional health authorities to facilitate distribution outreach programs and mobile vaccination units.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include AstraZeneca plc and Johnson & Johnson Services, Inc.
Upto 15% Off
USD
$1999 $1799
$3099 $2789
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Type |
|
| Breakup by Route of Administration |
|
| Breakup by Disease Indication |
|
| Breakup by Age |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share